In line Q3; guidance upgraded for FY19
11/11/19 -"The ongoing generic erosion in Onfi and Sabril was partly offset by a robust performance in the core portfolio across regions, resulting in a FY19 guidance upgrade. While we believe that Lundbeck’s ..."
Pages
51
Language
English
Published on
11/11/19
You may also be interested by these reports :
17/04/24
Q1 sales exceeded expectations, driven by a strong performance from the Companion Animal segment. The Farm Animal segment was however held back by a ...
16/04/24
Preview: Positive 1Q24 driven by clinical developments of portfolio companies
15/04/24
Investor appetite for Merck KGaA (Add, Germany) shares has been somewhat subdued since we last teased the name (15/03/2021). At that time, the ...
15/04/24
Turnaround story on track – TP increased to CHF 30.00 (from CHF 25.00) – Add reiterated